|
RFK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.632800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.368450E-04 |
| Normal-vs-Stage2 |
7.782200E-02 |
| Normal-vs-Stage3 |
4.460900E-03 |
| Normal-vs-Stage4 |
5.262800E-01 |
| Stage1-vs-Stage2 |
5.884600E-01 |
| Stage1-vs-Stage3 |
7.716800E-01 |
| Stage1-vs-Stage4 |
3.538300E-02 |
| Stage2-vs-Stage3 |
7.810000E-01 |
| Stage2-vs-Stage4 |
2.818200E-01 |
| Stage3-vs-Stage4 |
1.049420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.189500E-04 |
| Normal-vs-AfricanAmerican |
2.462000E-01 |
| Normal-vs-Asian |
3.464900E-03 |
| Caucasian-vs-AfricanAmerican |
6.699600E-01 |
| Caucasian-vs-Asian |
3.961600E-01 |
| AfricanAmerican-vs-Asian |
3.785800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.606150E-01 |
| Normal-vs-Female |
2.49489999999408E-05 |
| Male-vs-Female |
8.843900E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.70159999999853E-05 |
| Normal-vs-Age(41-60Yrs) |
2.879900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.064100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.973000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.796190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.391900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.113800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.319000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.193200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.685800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.598400E-01 |
| Classical-VS-Follicular |
7.677900E-02 |
| Classical-VS-Other |
1.243390E-01 |
| Classical-VS-Normal |
4.28340000000471E-05 |
| Tall-VS-Follicular |
1.688400E-01 |
| Tall-VS-Other |
7.584200E-02 |
| Tall-VS-Normal |
6.122900E-03 |
| Follicular-VS-Other |
3.320000E-01 |
| Follicular-VS-Normal |
8.358000E-02 |
| Other-VS-Normal |
6.664600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.003400E-03 |
| Normal-vs-N1 |
8.096100E-02 |
| N0-vs-N1 |
8.727200E-01 |
|
|
